Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Cancer Letters
|
December 3, 2014
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma
Vasilios Liapis, Agatha Labrinidis, Irene Zinonos, et al.
Anticancer Research
|
December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
Nature Biomedical Engineering
|
July 3, 2023
Simultaneous quantitative imaging of two PET radiotracers via the detection of positron-electron annihilation and prompt gamma emissions
Edwin C Pratt, Alejandro Lopez-Montes, Alessia Volpe, et al.
Cancer Medicine
|
January 11, 2016
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models
Vasilios Liapis, Irene Zinonos, Agatha Labrinidis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M Carter, et al.
Blood Cancer Discovery
|
October 22, 2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma
Agatha Labrinidis, Peter Diamond, Sally Martin, et al.
Neurocritical Care
|
December 12, 2022
Characterization of Cerebral Hemodynamics with TCD in Patients Undergoing VA-ECMO and VV-ECMO: a Prospective Observational Study
Giorgio Caturegli, Lucy Q Zhang, Yunis Mayasi, et al.
Cancer Medicine
|
August 12, 2017
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
Vasilios Liapis, Aneta Zysk, Mark DeNichilo, et al.
The American Journal of Pathology
|
October 23, 2016
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling
Amita Shukla-Dave, Mireia Castillo-Martin, Ming Chen, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Cancer Letters
|
December 3, 2014
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma
Vasilios Liapis, Agatha Labrinidis, Irene Zinonos, et al.
Anticancer Research
|
December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
Nature Biomedical Engineering
|
July 3, 2023
Simultaneous quantitative imaging of two PET radiotracers via the detection of positron-electron annihilation and prompt gamma emissions
Edwin C Pratt, Alejandro Lopez-Montes, Alessia Volpe, et al.
Cancer Medicine
|
January 11, 2016
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models
Vasilios Liapis, Irene Zinonos, Agatha Labrinidis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M Carter, et al.
Blood Cancer Discovery
|
October 22, 2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma
Agatha Labrinidis, Peter Diamond, Sally Martin, et al.
Neurocritical Care
|
December 12, 2022
Characterization of Cerebral Hemodynamics with TCD in Patients Undergoing VA-ECMO and VV-ECMO: a Prospective Observational Study
Giorgio Caturegli, Lucy Q Zhang, Yunis Mayasi, et al.
Cancer Medicine
|
August 12, 2017
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
Vasilios Liapis, Aneta Zysk, Mark DeNichilo, et al.
The American Journal of Pathology
|
October 23, 2016
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling
Amita Shukla-Dave, Mireia Castillo-Martin, Ming Chen, et al.
Page
of 8